COMMON drugs for high blood pressure and anxiety may provide a new lifeline for women with resistant breast cancer.
Scientists say there is growing evidence to show that beta-blockers can stop breast cancer spreading and save lives.
The latest research, on more than 400 UK breast cancer patients, confirms earlier results indicating that beta-blockers can aid survival.
Last year findings published in the journal Oncotarget showed that women taking the drugs before an operation for breast cancer were less likely to have died several years later.
The new study showed that taking beta-blockers led to a 70pc reduction in death rates over a 10 year period.
The drug tamoxifen is often given after surgery to prevent recurrence, but in some 50pc of cases the disease becomes resistant to tamoxifen treatment. Scientists believed beta-blockers could be used in these cases.